Join Angel at BIO where Dr Stewart White, Commercial Director and Acting CEO, will be participating in a roundtable discussion on "Scaling up by Scaling Out: Biomanufacturing for Cell and Engineered Tissue Therapy" to be held on June 20th from 10:00-11:30 AM. Susan McKee, Business Development Manager, will be presenting on "Tackling the Challenges in the Manufacturing of Cell Based Therapies" from 3.30-3.55 PM on June 20th in the BioProcess Theater in the exhibit hall.
Angel is exhibiting in the BIO Process Zone this year. Please come and visit us at Booth 980, or request a partnering meeting with us.
BioTrinity is the largest gathering of the UK's Bioindustry and is Europe's fastest growing Biopartnering and Investment Conference. Angel is exhibiting at Booth 55; please come along and meet the team.
Angel is pleased to be sponsoring this event, bringing together international experts to share knowledge and experience with the aim of accelerating Progress to Therapy in Regenerative Medicine.
Dr Stewart White has been invited to present on Angel's Cell Therapy services and to participate in an interactive workshop to discuss the challenges faced in the industry today.
BIO-Europe Spring® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe®, and continues the tradition of providing life science companies with high caliber partnering opportunities.
Angel is exhibiting at Booth 5.
Please come along and speak to our Business Development Manager, Andrew Carver, or arrange to meet with our Commercial Director, Stewart White, through the on-line partnering system.
Learning Curve: Challenges in the cGMP Manufacturing of Cell Therapies
By: Susan Dana Jones, PhD., Howard L Levine, PhD., and Susan McKee
This article discusses the parallels between hurdles faced today in the manufacture of cell therapy products with those faced by the biotechnology industry in the early days of monoclonal antibody protein production.
Reprinted with permission of European Biopharmaceutical Review, January 2012
Current issue of EBR
Angel Biotechnology Holdings plc, (AIM:ABH), the biopharmaceutical contract manufacturer, wishes to comment on the ruling issued on Tuesday 18 October by the European Court of Justice prohibiting the patentability of human embryonic stem cells.
'Applying the Latest Scientific and Technical Innovations to Build the Bridge from Development to Commercialisation' will be attended by Angela Scott, Director of Operations – Cell Therapy.
Dr Paul Harper, Executive Chairman, and Mr Andrew Carver, Business Development Manager, have been invited to present on Angel's Cell Therapy services.
BIO-Europe® is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Angel is exhibiting at Booth 92b; please come along and speak to our Business Development Managers Andrew Carver and Susan McKee.
The World Stem Cell Summit is the largest interdisciplinary, networking meeting of stem cell stakeholders, uniting the diverse regenerative medicine community. Angel is a Bronze Sponsor and will be exhibiting at the event; please come along and speak to our Business Development Managers Andrew Carver and Susan McKee.
BioPharm America™ is where biotech industry partnerships get started. Angel will meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Angel is exhibiting at Booth 19, please come along and speak to our Business Development Managers Andrew Carver and Susan McKee.
BIO 2011 is the world's largest gathering of thought leaders and decision makers in biotechnology. The Conference consists of four intensive days of education, partnering and networking and will provide unparalleled exposure to high-level executives from around the globe. Angel's Chief Operating Officer, Gordon Sherriff, is presenting a talk on manufacturing cell therapy products: the route to successful commercialisation in the BioProcess Theatre. Angel is also exhibiting at Booth 2024; please come along and speak to our Business Development Managers Andrew Carver and Susan McKee.
The ISSCR Annual Meeting is the preeminent international stem cell meeting of the foremost stem cell professionals from public, private, academic and government settings.
Andrew Carver, Business Development Manager at Angel, is attending the conference. www.isscr.org/meetings/index.cfm
Angel's MHRA licensed facilities are located at Pentlands Science Park on the outskirts of Edinburgh.